146 related articles for article (PubMed ID: 19608395)
1. Biomarkers of lung damage associated with tobacco smoke in induced sputum.
Comandini A; Rogliani P; Nunziata A; Cazzola M; Curradi G; Saltini C
Respir Med; 2009 Nov; 103(11):1592-613. PubMed ID: 19608395
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive evaluation of airway inflammation in asthmatic patients who smoke: implications for application in clinical practice.
Bessa V; Tseliou E; Bakakos P; Loukides S
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):226-32; quiz 232-4, 278. PubMed ID: 18814444
[TBL] [Abstract][Full Text] [Related]
4. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
5. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
Nowak D; Kasielski M; Antczak A; Pietras T; Bialasiewicz P
Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
[TBL] [Abstract][Full Text] [Related]
6. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories.
Kennedy TC; Proudfoot SP; Franklin WA; Merrick TA; Saccomanno G; Corkill ME; Mumma DL; Sirgi KE; Miller YE; Archer PG; Prochazka A
Cancer Res; 1996 Oct; 56(20):4673-8. PubMed ID: 8840983
[TBL] [Abstract][Full Text] [Related]
7. Effects of ozone on normal and potentially sensitive human subjects. Part II: Airway inflammation and responsiveness to ozone in nonsmokers and smokers.
Frampton MW; Morrow PE; Torres A; Voter KZ; Whitin JC; Cox C; Speers DM; Tsai Y; Utell MJ
Res Rep Health Eff Inst; 1997 Jun; (78):39-72; discussion 81-99. PubMed ID: 9387196
[TBL] [Abstract][Full Text] [Related]
8. Laboratory markers for COPD in "susceptible" smokers.
Tzortzaki EG; Tsoumakidou M; Makris D; Siafakas NM
Clin Chim Acta; 2006 Feb; 364(1-2):124-38. PubMed ID: 16139829
[TBL] [Abstract][Full Text] [Related]
9. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
Islam SS; Schottenfeld D
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
[TBL] [Abstract][Full Text] [Related]
10. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
[TBL] [Abstract][Full Text] [Related]
11. IL-18 in induced sputum and airway hyperresponsiveness in mild asthmatics: effect of smoking.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Dec; 103(12):1919-25. PubMed ID: 19539457
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects.
Malerba M; Ragnoli B; Corradi M
Monaldi Arch Chest Dis; 2008 Sep; 69(3):128-33. PubMed ID: 19065847
[TBL] [Abstract][Full Text] [Related]
13. Effects of tobacco exposure on lung health and pulmonary biomarkers in young, healthy smokers aged 12-25 years: a systematic review.
Kotz D; van de Kant K; Jöbsis Q; van Schayck CP
Expert Rev Respir Med; 2007 Dec; 1(3):403-18. PubMed ID: 20477179
[TBL] [Abstract][Full Text] [Related]
14. Consequences of passive smoking in home environment.
Kałucka S
Przegl Lek; 2007; 64(10):632-41. PubMed ID: 18409274
[TBL] [Abstract][Full Text] [Related]
15. Induced sputum and exhaled nitric oxide as noninvasive markers of airway inflammation from work exposures.
Lemiere C
Curr Opin Allergy Clin Immunol; 2007 Apr; 7(2):133-7. PubMed ID: 17351465
[TBL] [Abstract][Full Text] [Related]
16. Smoking affects eotaxin levels in asthma patients.
Krisiukeniene A; Babusyte A; Stravinskaite K; Lotvall J; Sakalauskas R; Sitkauskiene B
J Asthma; 2009 Jun; 46(5):470-6. PubMed ID: 19544167
[TBL] [Abstract][Full Text] [Related]
17. Productive cough is an independent risk factor for the development of COPD in former smokers.
Yamane T; Hattori N; Kitahara Y; Haruta Y; Sasaki H; Yokoyama A; Kohno N
Respirology; 2010 Feb; 15(2):313-8. PubMed ID: 20070589
[TBL] [Abstract][Full Text] [Related]
18. Higher levels of the anti-inflammatory protein CC10 are associated with improvement in bronchial dysplasia and sputum cytometric assessment in individuals at high risk for lung cancer.
Chen J; Lam S; Pilon A; McWilliams A; Macaulay C; Szabo E
Clin Cancer Res; 2008 Mar; 14(5):1590-7. PubMed ID: 18316584
[TBL] [Abstract][Full Text] [Related]
19. The acute effect of smoking in healthy and asthmatic smokers.
Papaioannou AI; Koutsokera A; Tanou K; Kiropoulos TS; Tsilioni I; Oikonomidi S; Liadaki K; Pournaras S; Gourgoulianis KI; Kostikas K
Eur J Clin Invest; 2010 Feb; 40(2):103-9. PubMed ID: 19912318
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers.
Koczulla AR; Noeske S; Herr C; Jörres RA; Römmelt H; Vogelmeier C; Bals R
Respiration; 2010; 79(1):61-7. PubMed ID: 19816000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
